Most emerging markets have low penetration rates of generic generics due to: i) the lack of a regulatory vehicle for automatic substitution; and ii) consumer mistrust of product quality. Instead, emerging-market countries generally have a strong market presence by branded generics from well-known multinational companies.
Market Data 
Markets 
AI
